Expertise in
31
conditions

Dr. Praveen K. Tumula

Oncology
Texas Oncology Pharmacy-Amarillo
1826 Point West Pkwy, 
Amarillo, TX 
Accepting New Patients
Offers Telehealth
Expertise in
31
conditions
Texas Oncology Pharmacy-Amarillo
1826 Point West Pkwy, 
Amarillo, TX 

Overview

Praveen Tumula is an Oncologist practicing medicine in Amarillo, Texas.

Dr. Tumula is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Lung Cancer, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 5 peer reviewed articles and participating in 4 clinical trials. Dr. Tumula is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in TX

Hospital Affiliations

Ochiltree General Hospital
Bsa Hospital
Quail Creek Surgical Hospital
Northwest Texas Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
FirstCare
  • HMO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Scott and White Health
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Texas Oncology Pharmacy-Amarillo
1826 Point West Pkwy, Amarillo, TX 79124

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III, Multi-center, Open-label, Randomized Study of Oral Asciminib Versus Investigator Selected TKI in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase
A Phase III, Multi-center, Open-label, Randomized Study of Oral Asciminib Versus Investigator Selected TKI in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug
Study Drugs: Imatinib, Nilotinib, Bosutinib, Dasatinib, Asciminib
Study Phase: Phase 3
A Dual-cohort, Open-label, Phase 2 Study of Brentuximab Vedotin and CHP (A+CHP) in the Frontline Treatment of Subjects With Peripheral T-cell Lymphoma (PTCL) With Less Than 10% CD30 Expression
A Dual-cohort, Open-label, Phase 2 Study of Brentuximab Vedotin and CHP (A+CHP) in the Frontline Treatment of Subjects With Peripheral T-cell Lymphoma (PTCL) With Less Than 10% CD30 Expression
Enrollment Status: Completed
Publish Date: August 13, 2026
Intervention Type: Drug
Study Drugs: Brentuximab vedotin, Cyclophosphamide, Doxorubicin, Prednisone
Study Phase: Phase 2
A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
Study Drugs: Pirtobrutinib, Idelalisib, Bendamustine, Rituximab
Study Phase: Phase 3
View 2 Less Clinical Trials

5 Total Publications

Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies.
Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies.
Journal: Haematologica
Published: July 10, 2023
Similar Doctors
Expertise in
39
conditions
Expertise in
39
conditions
Referral may be required

Bsa Harrington Cancer Center

1751 Wallace Blvd, 
Amarillo, TX 
 (0.5 miles away)
806-212-4673
Languages Spoken:
English
See accepted insurances

Anita Ravipati is an Oncologist practicing medicine in Amarillo, Texas. Dr. Ravipati is highly rated in 39 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Colorectal Cancer, and Familial Colorectal Cancer.

Expertise in
39
conditions
Expertise in
39
conditions
Referral may be required

Bsa Harrington Cancer Center

1751 Wallace Blvd, 
Amarillo, TX 
 (0.5 miles away)
806-212-4673
Languages Spoken:
English
See accepted insurances

Milan Patel is an Oncologist practicing medicine in Amarillo, Texas. Dr. Patel is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Colorectal Cancer, Neuroendocrine Tumor, and Bone Marrow Aspiration.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required
Before you request

Primary Care Of Amarillo PLLC

7201 SW 34th Ave, 
Amarillo, TX 
 (1.3 miles away)
806-310-0500
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Thahir Farzan is an Oncologist practicing medicine in Amarillo, Texas. Dr. Farzan is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Cancer, Ureteroscopy, and Ureteral Reconstruction. Dr. Farzan is currently accepting new patients.

Frequently Asked Questions about Dr. Praveen K. Tumula

How do I make an appointment with Dr. Praveen K. Tumula?

You can book an appointment with Dr. Praveen K. Tumula by calling their office at 806-358-8654. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Praveen K. Tumula a top-rated expert for Myelodysplastic Syndrome (MDS)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Praveen K. Tumula is classified as an Distinguished expert for Myelodysplastic Syndrome (MDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Praveen K. Tumula specialize in?

While Dr. Praveen K. Tumula is a Oncology, they have specific expertise in Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), and Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Praveen K. Tumula participate in research or clinical trials?

Yes. Dr. Praveen K. Tumula has published 5 articles and abstracts on conditions like Myelodysplastic Syndrome (MDS). You can view a list of Dr. Praveen K. Tumula's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Praveen K. Tumula accept my insurance?

Dr. Praveen K. Tumula accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 806-358-8654 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tumula's expertise for a condition
ConditionClose
    View All 10 Distinguished Conditions
    View All 21 Advanced Conditions
    View All 70 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile